PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...

A trial found no meaningful difference in detection of clinically significantly prostate cancer between multiparametric MRI-based and microultrasound-based biopsy techniques.

Researchers from around the U.K., led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is ...

Investigators of a prospective validation study highlighted the potential of a urine-based assay to reduce surgical biopsies deemed unnecessary. A urine-based biopsy displayed a 97.8% sensitivity rate ...

Commenting on a draft guidance on taking tissue biopsies in clinical trials, stakeholders said they want the US Food and Drug Administration (FDA) to address the use of alternative methods, such as ...

In the past week, Francis Collins, the former director of the National Institutes of Health, wrote in the Washington Post about his recent diagnosis of an aggressive form of prostate cancer.